missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human TRIT1 (aa 266-356) Control Fragment Recombinant Protein
Recombinant Protein
Supplier: Invitrogen™ RP108769
Description
Highest antigen sequence indentity to the following orthologs: Mouse (%), Rat (%). This recombinant protein control fragment may be used for blocking experiments. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
TRIT1 is responsible for the modification of A37 to isopentenyl A37 of both cytosolic and mitochondrial tRNAs.Greener Choice Claims
- Environmental benefits include:
- Renewable Energy
Specifications
Q9H3H1 | |
Blocking Assay, Control | |
54802 | |
100 ÎĽL | |
2310075G14Rik; AI314189; AI314635; AV099619; GRO1; hGRO1; IPP transferase; IPPT; IPT; IPTase; isopentenyl-diphosphate:tRNA isopentenyltransferase; MOD5; Trit1; tRNA dimethylallyltransferase; tRNA dimethylallyltransferase, mitochondrial; tRNA isopentenylpyrophosphate transferase; tRNA isopentenyltransferase; tRNA isopentenyltransferase 1; tRNA isopentenyltransferase, mitochondrial | |
Trit1 | |
Human | |
His-ABP-tag | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
≥5.0 mg/mL | |
1 M urea, PBS with no preservative; pH 7.4 | |
Human TRIT1 (aa 266-356) Control Fragment | |
RUO | |
TRIT1 | |
Unconjugated | |
Recombinant | |
KNVSENSQDYQHGIFQSIGFKEFHEYLITEGKCTLETSNQLLKKGIEALKQVTKRYARKQNRWVKNRFLSRPGPIVPPVYGLEVSDVSKWE | |
E. coli | |
>80% by SDS-PAGE and Coomassie blue staining |